Fast Five Quiz: How Much Do You Know About HIV?

Michael Stuart Bronze, MD; Nicholas J. Bennett, MBBCh, PhD, MA(Cantab)


June 01, 2023

An ARV regimen for a patient who is treatment-naive generally consists of a dual NRTI regimen administered in combination with a third active ARV drug from one of three drug classes: an INSTI, an NNRTI or a PI with a PK enhancer.

When choosing between an INSTI, PI or NNRTI in an initial ARV regimen, there are several factors that should be considered. These include drug efficacy, barrier to resistance, possible adverse effects, drug interactions, convenience, the patient’s comorbidities and associated medications and whether the individual has been given long-acting cabotegravir as preexposure prophylaxis.

Learn more about HIV treatment approaches.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.